Form 4 for HUM Humana
Accepted 2024-02-21 00:00:00 ET · period of report 2024-02-20 · accession 0001062993-24-003797 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-02-21 | 2024-02-20 | HUM | Mesquita Jorge S. | Dir | P - Purchase | $367.09 | +545 | 2,578 | +27% | +$200.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Humana Common | 2024-02-20 | P | A | 545 | $367.09 | 2,578 | I See Footnote | — | — | (F3) Shares acquired through open-market purchase at reported weighted average price. (F1) Includes 430 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting 12/31/24. (F2) Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003. |